Posted in | News | Business | Automotive Materials

Magnesium International Announces First Commercial Purchase Order for Magsheet

Oct 27 2005

Related Stories

Magnesium International Limited (MIL) has announced that its wholly owned magsheet subsidiary has secured its first commercial purchase order for 3 mm magnesium alloy sheet from a Japanese customer.

This sheet will be produced by the trial production plant at Clayton, Victoria using the Twin Roll casting (“TRC”) technology which MIL has under option.

MIL is actively working with a broad range of potential customers in the Camera, Computer and Communication (“CCC”) and automotive markets for the application of magnesium alloy sheet using the TRC process. This technology, which is production ready, provides a significant reduction in the cost of producing magnesium alloy sheet.

http://www.mgil.com.au

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback